Drug Discovery & Development

Drug Discovery & Development company information, Employees & Contact Information

Drug Discovery and Development covers strategies and technologies related to pharmaceutical research and development and drug formulation. We report on innovative drug introductions and promising pipeline candidates from Big Pharma and smaller players, as well as relevant clinical trial trends. The publication also covers promising technological developments relevant to the biotech, biopharma and pharma industries, including advances in artificial intelligence, genomic/proteomic sequencing and microscopy. Other areas of focus include orphan drugs, drug advances for oncology, neurological disease and infectious disease including vaccines and other therapies for COVID-19. Our content includes staff-written articles as well as contributed content from experts. The publication serves the pharmaceutical, biopharmaceutical and biotechnology industries, contract research organizations, government laboratories, universities, hospitals, medical centers and others within the life science marketplace. Our readers include informatics specialists, staff scientists, research scientists, corporate and lab management and scientists conducting and leading research within the field. Drug Discovery and Development is a MassDevice-affiliated pharmaceutical industry news website, owned by Cleveland-based WTWH Media. We stand by journalistic ethics to provide the most up-to-date, accurate and fairly reported information for our readers. Sign up for our newsletter: https://www.drugdiscoverytrends.com/enews-signup/ For advertising inquiries, visit our Media Guide: https://marketing.wtwhmedia.com/2023-pharma-media-guide
Looking for a particular Drug Discovery & Development employee's phone or email?

Drug Discovery & Development Questions

News

Top pharmaceuticals of H1 2025: Ozempic and Mounjaro enter top three - drugdiscoverytrends.com

Top pharmaceuticals of H1 2025: Ozempic and Mounjaro enter top three drugdiscoverytrends.com

NIH announces end to funding for animal-only studies - drugdiscoverytrends.com

NIH announces end to funding for animal-only studies drugdiscoverytrends.com

Bispecific antibodies: The next generation of precision therapeutics - drugdiscoverytrends.com

Bispecific antibodies: The next generation of precision therapeutics drugdiscoverytrends.com

Why peptide drug discovery is experiencing a resurgence - drugdiscoverytrends.com

Why peptide drug discovery is experiencing a resurgence drugdiscoverytrends.com

GLP-1 vs oncology market: Keytruda leads in 2028; Mounjaro tops by 2030 - drugdiscoverytrends.com

GLP-1 vs oncology market: Keytruda leads in 2028; Mounjaro tops by 2030 drugdiscoverytrends.com

Top 25 investors in pharma R&D in 2024 - drugdiscoverytrends.com

Top 25 investors in pharma R&D in 2024 drugdiscoverytrends.com

AI in drug safety with governance and human oversight - drugdiscoverytrends.com

AI in drug safety with governance and human oversight drugdiscoverytrends.com

From data to drug candidates: Optimizing informatics for ML and GenAI - drugdiscoverytrends.com

From data to drug candidates: Optimizing informatics for ML and GenAI drugdiscoverytrends.com

Safeguarding innovation: The importance of a sound AI policy in pharmaceutical research and development - drugdiscoverytrends.com

Safeguarding innovation: The importance of a sound AI policy in pharmaceutical research and development drugdiscoverytrends.com

Why molecular glue degraders are emerging as a key modality in drug discovery - drugdiscoverytrends.com

Why molecular glue degraders are emerging as a key modality in drug discovery drugdiscoverytrends.com

AI agents in pharma: Governance emerges as key to scaling - drugdiscoverytrends.com

AI agents in pharma: Governance emerges as key to scaling drugdiscoverytrends.com

AI-informed workflows can help trim clinical-writing hours by 50% or more - drugdiscoverytrends.com

AI-informed workflows can help trim clinical-writing hours by 50% or more drugdiscoverytrends.com

Parallel Bio’s $21M in Series A will drive aim to trim $2B and 9 years from drug development timelines - drugdiscoverytrends.com

Parallel Bio’s $21M in Series A will drive aim to trim $2B and 9 years from drug development timelines drugdiscoverytrends.com

Labcorp ramps up oncology R&D speed with advanced diagnostics and digital pathology - drugdiscoverytrends.com

Labcorp ramps up oncology R&D speed with advanced diagnostics and digital pathology drugdiscoverytrends.com

AbbVie - drugdiscoverytrends.com

AbbVie drugdiscoverytrends.com

Pharma 50 Deep Dive: Oncology leads with $110B in sales; GLP-1s continue surge - drugdiscoverytrends.com

Pharma 50 Deep Dive: Oncology leads with $110B in sales; GLP-1s continue surge drugdiscoverytrends.com

The 2025 Drug Discovery & Development Pharma 50 Report: Deep Dives - drugdiscoverytrends.com

The 2025 Drug Discovery & Development Pharma 50 Report: Deep Dives drugdiscoverytrends.com

Takeda's oral TYK2 inhibitor matches biologic efficacy - drugdiscoverytrends.com

Takeda's oral TYK2 inhibitor matches biologic efficacy drugdiscoverytrends.com

AI-guided hunt points to PHGDH as an upstream drug target in Alzheimer’s disease - drugdiscoverytrends.com

AI-guided hunt points to PHGDH as an upstream drug target in Alzheimer’s disease drugdiscoverytrends.com

Unravelling the challenge of AI inventorship in healthcare - drugdiscoverytrends.com

Unravelling the challenge of AI inventorship in healthcare drugdiscoverytrends.com

Insilico’s rentosertib clears a phase 2a hurdle - drugdiscoverytrends.com

Insilico’s rentosertib clears a phase 2a hurdle drugdiscoverytrends.com

The latest on Lumen Biosience's experimental c. diff biologic - drugdiscoverytrends.com

The latest on Lumen Biosience's experimental c. diff biologic drugdiscoverytrends.com

FDA 2024 analysis: Small molecule resilience & oncology rebounds - drugdiscoverytrends.com

FDA 2024 analysis: Small molecule resilience & oncology rebounds drugdiscoverytrends.com

Scientific AI must be trustworthy and explainable - drugdiscoverytrends.com

Scientific AI must be trustworthy and explainable drugdiscoverytrends.com

How genetic validation is transforming biotech industry in 2025 - drugdiscoverytrends.com

How genetic validation is transforming biotech industry in 2025 drugdiscoverytrends.com

How conversational AI can detect pharma safety events - drugdiscoverytrends.com

How conversational AI can detect pharma safety events drugdiscoverytrends.com

JPM 2025: $1B women's health and RNAi innovations featured - drugdiscoverytrends.com

JPM 2025: $1B women's health and RNAi innovations featured drugdiscoverytrends.com

Shasqi's click chemistry platform shows complete tumor regression - drugdiscoverytrends.com

Shasqi's click chemistry platform shows complete tumor regression drugdiscoverytrends.com

PROTAC development faces key preclinical testing hurdles - drugdiscoverytrends.com

PROTAC development faces key preclinical testing hurdles drugdiscoverytrends.com

2024: The year AI drug discovery and protein structure prediction took center stage—2025 set to amplify growth - drugdiscoverytrends.com

2024: The year AI drug discovery and protein structure prediction took center stage—2025 set to amplify growth drugdiscoverytrends.com

Menarini and Insilico announce $550M deal for new cancer therapy - drugdiscoverytrends.com

Menarini and Insilico announce $550M deal for new cancer therapy drugdiscoverytrends.com

Projecting the top 20 Big Pharma firms of FY2024 - drugdiscoverytrends.com

Projecting the top 20 Big Pharma firms of FY2024 drugdiscoverytrends.com

Best-selling pharmaceuticals of 2023 reveal a shift in pharma landscape - drugdiscoverytrends.com

Best-selling pharmaceuticals of 2023 reveal a shift in pharma landscape drugdiscoverytrends.com

Exploring the impact of generative AI in drug discovery | DDD - drugdiscoverytrends.com

Exploring the impact of generative AI in drug discovery | DDD drugdiscoverytrends.com

50 best-selling pharmaceuticals of 2022: Market leaders and trends - drugdiscoverytrends.com

50 best-selling pharmaceuticals of 2022: Market leaders and trends drugdiscoverytrends.com

IRA spurs pharma revenue management overhaul - drugdiscoverytrends.com

IRA spurs pharma revenue management overhaul drugdiscoverytrends.com

Pharma50: 50 of 2021’s Best-Selling Pharmaceuticals - drugdiscoverytrends.com

Pharma50: 50 of 2021’s Best-Selling Pharmaceuticals drugdiscoverytrends.com

Unlearn's digital twins cut timelines for clinical trials by 25%-plus - drugdiscoverytrends.com

Unlearn's digital twins cut timelines for clinical trials by 25%-plus drugdiscoverytrends.com

NVIDIA & AWS Alliance: BioNeMo leap in AI pharma research - drugdiscoverytrends.com

NVIDIA & AWS Alliance: BioNeMo leap in AI pharma research drugdiscoverytrends.com

Rounding up the pharma firms investing the most in 2023 - drugdiscoverytrends.com

Rounding up the pharma firms investing the most in 2023 drugdiscoverytrends.com

Top 50 Pharma: Oncology patent leaders 2024 - drugdiscoverytrends.com

Top 50 Pharma: Oncology patent leaders 2024 drugdiscoverytrends.com

30 biotech startups leading in pharmaceutical innovation - drugdiscoverytrends.com

30 biotech startups leading in pharmaceutical innovation drugdiscoverytrends.com

Insilico Medicine achieves AI drug discovery breakthrough - drugdiscoverytrends.com

Insilico Medicine achieves AI drug discovery breakthrough drugdiscoverytrends.com

Transforming pharmacovigilance through automation - drugdiscoverytrends.com

Transforming pharmacovigilance through automation drugdiscoverytrends.com

Atomwise's AI-driven drug screening heralds a generational shift - drugdiscoverytrends.com

Atomwise's AI-driven drug screening heralds a generational shift drugdiscoverytrends.com

Booming trends in the GLP-1 drug market: Key players - drugdiscoverytrends.com

Booming trends in the GLP-1 drug market: Key players drugdiscoverytrends.com

Anti-obesity drugs to command a $44 billion market by 2030 - drugdiscoverytrends.com

Anti-obesity drugs to command a $44 billion market by 2030 drugdiscoverytrends.com

Forging an AI-driven path for more effective drug development - drugdiscoverytrends.com

Forging an AI-driven path for more effective drug development drugdiscoverytrends.com

Top pharma R&D spenders: Meet the big 25 in pharma investments - drugdiscoverytrends.com

Top pharma R&D spenders: Meet the big 25 in pharma investments drugdiscoverytrends.com

Tirzepatide cuts heart failure risk in HFpEF patients - drugdiscoverytrends.com

Tirzepatide cuts heart failure risk in HFpEF patients drugdiscoverytrends.com

Innovations in Baculovirus–Insect Cell Expression Systems - drugdiscoverytrends.com

Innovations in Baculovirus–Insect Cell Expression Systems drugdiscoverytrends.com

AstraZeneca, Daiichi Sankyo's Enhertu has new breakthrough therapy nod - drugdiscoverytrends.com

AstraZeneca, Daiichi Sankyo's Enhertu has new breakthrough therapy nod drugdiscoverytrends.com

Zymeworks and its partner BeiGene expand zanidatamab pivotal trial in Asia - drugdiscoverytrends.com

Zymeworks and its partner BeiGene expand zanidatamab pivotal trial in Asia drugdiscoverytrends.com

Analyzing the biotech and pharma layoffs in 2024 - drugdiscoverytrends.com

Analyzing the biotech and pharma layoffs in 2024 drugdiscoverytrends.com

Eli Lilly's Mounjaro sales projected to triple in 2024 - drugdiscoverytrends.com

Eli Lilly's Mounjaro sales projected to triple in 2024 drugdiscoverytrends.com

Amgen finalizes Teneobio acquisition - drugdiscoverytrends.com

Amgen finalizes Teneobio acquisition drugdiscoverytrends.com

Pharma’s top 20 R&D spenders in 2021 - drugdiscoverytrends.com

Pharma’s top 20 R&D spenders in 2021 drugdiscoverytrends.com

Semaglutide and GLP-1: Effects on lean body mass still unclear - drugdiscoverytrends.com

Semaglutide and GLP-1: Effects on lean body mass still unclear drugdiscoverytrends.com

30 promising biotech startups: Scatter plot - drugdiscoverytrends.com

30 promising biotech startups: Scatter plot drugdiscoverytrends.com

Metrum Research Group names Michelle Johnson as its new CEO - drugdiscoverytrends.com

Metrum Research Group names Michelle Johnson as its new CEO drugdiscoverytrends.com

Hemophilia gene therapy Hemgenix is world's most expensive drug - drugdiscoverytrends.com

Hemophilia gene therapy Hemgenix is world's most expensive drug drugdiscoverytrends.com

Cloud-based generative AI: biopharma's next competitive edge - drugdiscoverytrends.com

Cloud-based generative AI: biopharma's next competitive edge drugdiscoverytrends.com

Why Kazakhstan and Georgia could be clinical trial hotspots - drugdiscoverytrends.com

Why Kazakhstan and Georgia could be clinical trial hotspots drugdiscoverytrends.com

SandboxAQ aims to reshape pharma with quantum-inspired tech - drugdiscoverytrends.com

SandboxAQ aims to reshape pharma with quantum-inspired tech drugdiscoverytrends.com

Pharma 2023 Half-year review reveals winners and losers - drugdiscoverytrends.com

Pharma 2023 Half-year review reveals winners and losers drugdiscoverytrends.com

Gate Neurosciences taps event-driven pharmacology in depression - drugdiscoverytrends.com

Gate Neurosciences taps event-driven pharmacology in depression drugdiscoverytrends.com

Daiichi Sankyo’s valemetostat fares well in lymphoma and leukemia study - drugdiscoverytrends.com

Daiichi Sankyo’s valemetostat fares well in lymphoma and leukemia study drugdiscoverytrends.com

The top drug discovery predictions of 2023 | Drug Discovery Trends - drugdiscoverytrends.com

The top drug discovery predictions of 2023 | Drug Discovery Trends drugdiscoverytrends.com

AI in drug development: How Janssen is exploring potential of AI - drugdiscoverytrends.com

AI in drug development: How Janssen is exploring potential of AI drugdiscoverytrends.com

Big Pharma's R&D ROI: Merck, Pfizer, J&J, AbbVie strategies - drugdiscoverytrends.com

Big Pharma's R&D ROI: Merck, Pfizer, J&J, AbbVie strategies drugdiscoverytrends.com

Lifileucel FDA approval advances cell therapy in solid tumors - drugdiscoverytrends.com

Lifileucel FDA approval advances cell therapy in solid tumors drugdiscoverytrends.com

How MetID studies can improve safety and efficacy in PROTAC drugs - drugdiscoverytrends.com

How MetID studies can improve safety and efficacy in PROTAC drugs drugdiscoverytrends.com

Unraveling complexities of AI in drug discovery with Verseon's CEO - drugdiscoverytrends.com

Unraveling complexities of AI in drug discovery with Verseon's CEO drugdiscoverytrends.com

QuantHealth's AI achieves 85% accuracy in clinical trial simulation - drugdiscoverytrends.com

QuantHealth's AI achieves 85% accuracy in clinical trial simulation drugdiscoverytrends.com

BioPhy tackles AI-driven drug development bottlenecks - drugdiscoverytrends.com

BioPhy tackles AI-driven drug development bottlenecks drugdiscoverytrends.com

Quantum computing could come to drug discovery, eventually - drugdiscoverytrends.com

Quantum computing could come to drug discovery, eventually drugdiscoverytrends.com

Is an AI drug discovery superorganism part of pharma's future - drugdiscoverytrends.com

Is an AI drug discovery superorganism part of pharma's future drugdiscoverytrends.com

Retatrutide study sees significant weight loss in obesity drug study - drugdiscoverytrends.com

Retatrutide study sees significant weight loss in obesity drug study drugdiscoverytrends.com

Why allosteric drugs represent a unique small molecule approach - drugdiscoverytrends.com

Why allosteric drugs represent a unique small molecule approach drugdiscoverytrends.com

Google DeepMind and Isomorphic Labs' AlphaFold 3 slashes protein modeling - drugdiscoverytrends.com

Google DeepMind and Isomorphic Labs' AlphaFold 3 slashes protein modeling drugdiscoverytrends.com

Nvidia launches BioNeMo Cloud to accelerate drug discovery - drugdiscoverytrends.com

Nvidia launches BioNeMo Cloud to accelerate drug discovery drugdiscoverytrends.com

Semaglutide dominates GLP-1 receptor agonist clinical trials - drugdiscoverytrends.com

Semaglutide dominates GLP-1 receptor agonist clinical trials drugdiscoverytrends.com

Prominent firms harnessing AI in drug discovery and development - drugdiscoverytrends.com

Prominent firms harnessing AI in drug discovery and development drugdiscoverytrends.com

NVIDIA and Recursion dish on AI-driven chip and drug design - drugdiscoverytrends.com

NVIDIA and Recursion dish on AI-driven chip and drug design drugdiscoverytrends.com

AWS aims to spearhead pharma cloud-enabled transformation - drugdiscoverytrends.com

AWS aims to spearhead pharma cloud-enabled transformation drugdiscoverytrends.com

Insilico Medicine wins IND approval for AI-designed USP1 inhibitor for cancer trials in U.S. and China - drugdiscoverytrends.com

Insilico Medicine wins IND approval for AI-designed USP1 inhibitor for cancer trials in U.S. and China drugdiscoverytrends.com

Top 10 global Big Pharma hubs in 2023 - drugdiscoverytrends.com

Top 10 global Big Pharma hubs in 2023 drugdiscoverytrends.com

Celgene to Partner with IBM on New Drug Safety Initiative - drugdiscoverytrends.com

Celgene to Partner with IBM on New Drug Safety Initiative drugdiscoverytrends.com

2024 pharma industry predictions: AI, virtual care, and R&D trends - drugdiscoverytrends.com

2024 pharma industry predictions: AI, virtual care, and R&D trends drugdiscoverytrends.com

Pharma's AI talent war: doubling down to gain an edge - drugdiscoverytrends.com

Pharma's AI talent war: doubling down to gain an edge drugdiscoverytrends.com

Amylyx Pharmaceuticals launches phase 2 trial for AMX0035 Wolfram syndrome therapy - drugdiscoverytrends.com

Amylyx Pharmaceuticals launches phase 2 trial for AMX0035 Wolfram syndrome therapy drugdiscoverytrends.com

Top 20 biotech startups raise $2.9B in Q1 2024 funding surge - drugdiscoverytrends.com

Top 20 biotech startups raise $2.9B in Q1 2024 funding surge drugdiscoverytrends.com

Pharma R&D spend and performance: an inconsistent relationship - drugdiscoverytrends.com

Pharma R&D spend and performance: an inconsistent relationship drugdiscoverytrends.com

Microsoft, 1910 Genetics eye biopharma breakthroughs - drugdiscoverytrends.com

Microsoft, 1910 Genetics eye biopharma breakthroughs drugdiscoverytrends.com

Pharma’s top 20 R&D spenders in 2020 - drugdiscoverytrends.com

Pharma’s top 20 R&D spenders in 2020 drugdiscoverytrends.com

GLP-1 obesity drugs to reshape pharma landscape - drugdiscoverytrends.com

GLP-1 obesity drugs to reshape pharma landscape drugdiscoverytrends.com

25 potential blockbusters to keep an eye on in 2023 - drugdiscoverytrends.com

25 potential blockbusters to keep an eye on in 2023 drugdiscoverytrends.com

Analyzing the biotech funding landscape in 2023: U.S. still out front - drugdiscoverytrends.com

Analyzing the biotech funding landscape in 2023: U.S. still out front drugdiscoverytrends.com

Biopharma innovation in 2023: The most popular stories - drugdiscoverytrends.com

Biopharma innovation in 2023: The most popular stories drugdiscoverytrends.com

Exploring role of generative AI in reshaping drug development - drugdiscoverytrends.com

Exploring role of generative AI in reshaping drug development drugdiscoverytrends.com

Top Drug Discovery & Development Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant